Alembic Pharmaceuticals Ltd (BOM:533573)
₹ 1029.25 -1.7 (-0.16%) Market Cap: 202.31 Bil Enterprise Value: 211.48 Bil PE Ratio: 31.31 PB Ratio: 4.14 GF Score: 91/100

Q3 2021 Alembic Pharmaceuticals Ltd Earnings Call Transcript

Jan 19, 2021 / 10:30AM GMT
Release Date Price: ₹1029.9 (-3.76%)
Operator

Ladies and gentlemen, good day, and welcome to the Alembic Pharmaceuticals Limited Q3 FY '21 Earnings Conference Call. We have with us today from the management, Mr. Pranav Amin, Managing Director; Mr. Shaunak Amin, Managing Director; Mr. R.K. Baheti, Director, Finance and CFO; Mr. Mitanshu Shah, Head, Finance; Mr. Jesal Shah, Head Strategy; and Mr. Ajay Kumar Desai, Senior Vice President, Finance. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. R.K. Baheti, Director, Finance and CFO. Thank you, and over to you, sir.

Raj Kumar Shreeram Baheti
Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director

Thank you very much. Good evening, everyone. Thank you all for joining the third quarter results conference call. I'm sure you would have received the results by now. However, let me briefly take you through the numbers for the quarter ended 9 months ended 31st March 2020 -- I'm sorry, 31st December 2020.

Let me begin with financials first. During the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot